Biology-guided deep learning predicts prognosis and cancer immunotherapy response

[1]  P. Rajpurkar,et al.  AI in health and medicine , 2022, Nature Medicine.

[2]  A. Madabhushi,et al.  Predicting cancer outcomes with radiomics and artificial intelligence in radiology , 2021, Nature Reviews Clinical Oncology.

[3]  Carola-Bibiane Schönlieb,et al.  Radiological tumor classification across imaging modality and histology , 2021, Nature Machine Intelligence.

[4]  R. Barzilay,et al.  Optimizing risk-based breast cancer screening policies with reinforcement learning , 2021, Nature Medicine.

[5]  R. Gillies,et al.  Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images , 2021, Journal for ImmunoTherapy of Cancer.

[6]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[7]  William Lotter,et al.  Robust breast cancer detection in mammography and digital breast tomosynthesis using an annotation-efficient deep learning approach , 2021, Nature Medicine.

[8]  R. Gillies,et al.  The Biological Meaning of Radiomic Features. , 2021, Radiology.

[9]  Y. Bang,et al.  Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial. , 2020, JAMA oncology.

[10]  J. Galon,et al.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy , 2020, Nature Reviews Cancer.

[11]  Ruijiang Li,et al.  Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit. , 2020, JCI insight.

[12]  Ruijiang Li,et al.  Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  Zhong-Ya Pan,et al.  Prognostic value of periostin in multiple solid cancers: A systematic review with meta‐analysis , 2020, Journal of cellular physiology.

[14]  David S. Melnick,et al.  International evaluation of an AI system for breast cancer screening , 2020, Nature.

[15]  David C. Kale,et al.  Do no harm: a roadmap for responsible machine learning for health care , 2019, Nature Medicine.

[16]  Martin J. Aryee,et al.  Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer , 2019, Cell.

[17]  G. Corrado,et al.  End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography , 2019, Nature Medicine.

[18]  J. Lunceford,et al.  Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy , 2018, Science.

[19]  P. Lambin,et al.  Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.

[20]  Laurence Zitvogel,et al.  The immune contexture in cancer prognosis and treatment , 2017, Nature Reviews Clinical Oncology.

[21]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[22]  Abhishek Das,et al.  Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization , 2016, 2017 IEEE International Conference on Computer Vision (ICCV).

[23]  Yinyin Yuan.  Spatial Heterogeneity in the Tumor Microenvironment. , 2016, Cold Spring Harbor perspectives in medicine.

[24]  Jen Jen Yeh,et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.

[25]  William A. Flavahan,et al.  Periostin Secreted by Glioblastoma Stem Cells Recruits M2 Tumor-associated Macrophages and Promotes Malignant Growth , 2014, Nature Cell Biology.

[26]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[27]  D. Komura,et al.  The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation. , 2014, The American journal of pathology.

[28]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2013, Nature Medicine.

[29]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[30]  Bauke Ylstra,et al.  Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer , 2012, Gut.

[31]  P. Austin.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[32]  Japanese Gastric Cancer Association.  Japanese gastric cancer treatment guidelines 2010 (ver. 3) , 2011, Gastric Cancer.